Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Glaukos Corporation - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GKOS
New York
3840
www.glaukos.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Glaukos Corporation
Should Glaukos’ (GKOS) Big 2026 Sales Target and ESOP Shelf Filing Require Action From Investors?
- Feb 26th, 2026 1:16 am
Strong Results with 38.1% Revenue Growth Lifted Glaukos (GKOS) in Q4
- Feb 23rd, 2026 6:28 am
Glaukos Corporation Q4 2025 Earnings Call Summary
- Feb 19th, 2026 6:08 pm
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data
- Feb 19th, 2026 3:41 pm
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead
- Feb 19th, 2026 3:34 pm
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition
- Feb 19th, 2026 3:23 pm
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale
- Feb 19th, 2026 3:15 pm
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider
- Feb 19th, 2026 1:12 pm
Why Analysts See Glaukos (GKOS) Story Shifting As iDose Repeat Dosing Takes Center Stage
- Feb 18th, 2026 9:36 pm
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook
- Feb 18th, 2026 8:53 am
Glaukos Corp (GKOS) Q4 2025 Earnings Call Highlights: Record Sales and Strong Growth Outlook
- Feb 17th, 2026 10:01 pm
Glaukos Q4 Earnings Call Highlights
- Feb 17th, 2026 8:34 pm
Glaukos (GKOS) Q4 2025 Earnings Call Transcript
- Feb 17th, 2026 4:30 pm
Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 17th, 2026 4:00 pm
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates
- Feb 17th, 2026 3:25 pm
Glaukos: Q4 Earnings Snapshot
- Feb 17th, 2026 2:44 pm
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
- Feb 17th, 2026 2:05 pm
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth
- Feb 12th, 2026 8:00 am
Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy?
- Feb 10th, 2026 8:00 am
Glaukos Gains FDA Green Light For Repeat iDose TR Use
- Feb 2nd, 2026 12:08 am
Scroll